Maria Sokolskaya

Dr. Maria Sokolskaya

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
VSV. A. Shvarts
V. A. Shvarts
STS. M. Talibova
S. M. Talibova
MSMaria Sokolskaya
Maria Sokolskaya
AIA. Yu. Ispiryan
A. Yu. Ispiryan
ESE. N. Shvarts
E. N. Shvarts
ВМВ. Ю. Мерзляков
В. Ю. Мерзляков
Aim. To compare the levels of novel biomarkers of systemic inflammation in pati­ents with and without atherosclerosis, as well as between groups of patients with atherosclerosis of different severity.Material and methods. Patients with suspected coronary artery disease after selective coronary angiography were included. The analysis included 901 patients with mean age of 61±10 years (men, 60% (n=549)). The patients were divided into two following groups: with and without atherosclerosis. The Propensity Score Matching method was used to adjust for baseline clinical differences.Results. In the group with atherosclerosis, the values of the systemic inflam­mation response index (SIRI), systemic immune-inflammation index (SII) and ag­gregate index of systemic inflammation (AISI) were significantly higher than in patients without atherosclerosis: 0,906 (0,632; 1,36) vs 0,745 (0,519; 1,02), p<0,001; 457 (350; 641) vs 425 (313; 547), p=0,005 and 233 (148; 346) vs 179 (121; 263), p1,05, area under the curve (AUC) confidence interval (CI) — 0,615 (0,571-0,658), p368, AUC CI — 0,572 (0,528-0,616), p=0,004, sensitivity — 72,1%, specificity — 43,4%; for AISI >248, AUC CI — 0,604 (0,560-0,647), p<0,001, sensitivity 47,4%, specificity 71,1%. SIRI had the highest AUC. When comparing 6 groups according to the Coronary Artery Surgery Study (CASS) classification, significant differences were found in SIRI and AISI, p1,05, for SII >368, for AISI >248.

31 July 2019 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
PDF file
OBO. L. Bockeria
O. L. Bockeria
TKT. N. Kanametov
T. N. Kanametov
Vladimir ShvartzVladimir Shvartz
Vladimir Shvartz
MSMaria Sokolskaya
Maria Sokolskaya
DZD. Sh. Zhuginisov
D. Sh. Zhuginisov
LBL. A. Bockeria
L. A. Bockeria

10 March 2021 in Gels
Verified
Journal Article
Open access
PDF file
Vladimir ShvartzVladimir Shvartz
Vladimir Shvartz
TKTeymuraz Kanametov
Teymuraz Kanametov
MSMaria Sokolskaya
Maria Sokolskaya
APAndrey Petrosyan
Andrey Petrosyan
TLTatyana Le
Tatyana Le
LBLeo Bockeria
Leo Bockeria
The objective of this study was to study the use of the hydrogel biopolymer based on sodium alginate (“Colegel”) with a drug substance—amiodarone—for the prevention of postoperative atrial fibrillation (POAF) in cardiac surgery. The experimental part of the study was performed on 46 rabbits. Five groups were formed: in the first group, the dose of amiodarone in hydrogel was 1 mg; in the second group—3 mg; in the third group—6 mg; in the fourth group, hydrogel was used without amiodarone; in the fifth group, 60 mg amiodarone was administered intravenously. The animals from each group were removed from the experiment for the pathomorphological study of the heart after 3, 7 and 14 days. The studied endpoints were: the heart rate control; the development of the blockades of the conduction system of the heart; and the development of inflammation according to laboratory pathomorphological studies. The translational clinical part involved a randomized clinical trial which included 60 patients, with an average age of 62 ± 8.5 years. All patients were randomized into two groups: the study group (n = 30, with the application of amiodarone hydrogel) and the control group (n = 30, without the application of amiodarone hydrogel). The dose of amiodarone in the hydrogel material was 60 mg for all patients. The heart rhythm was monitored during 5 days. The primary endpoint was the development of POAF. Secondary endpoints were: the dynamics of heart rate; the duration of the QT and PQ intervals; the development of blockades of the cardiac conduction system; as well as the dynamics of AST and ALT. According to the results of the experimental part, it was found that the method of the local epicardial delivery of amiodarone by the hydrogel material was safe. Hydrogel with amiodarone is effective for reducing the heart rate in the animal experiment in comparison to the control group and the group with the intravenous administration of the drug. The optimal dose of amiodarone in hydrogel was 1 mg per 1 kg. According to the results of the clinical part, it was found that the method of the local epicardial delivery of amiodarone as a hydrogel material proved its safety. Hydrogel with amiodarone at a dose of 60 mg was effective in preventing POAF in patients after coronary artery bypass grafting (CABG) operations in comparison to the control group (p < 0.001). The age and procedure of application of the amiodarone gel were significantly associated with POAF (p = 0.009 and p = 0.011, respectively). The use of hydrogel with amiodarone reduced the probability of developing POAF 18.9-fold. The method of the local epicardial delivery of amiodarone in the form of a hydrogel material is safe. The use of hydrogel with amiodarone after CABG reduced the probability of developing POAF.

9 March 2022 in Pathophysiology
Verified
Journal Article
Open access
PDF file
Vladimir ShvartzVladimir Shvartz
Vladimir Shvartz
MSMaria Sokolskaya
Maria Sokolskaya
APAndrey Petrosyan
Andrey Petrosyan
AIArtak Ispiryan
Artak Ispiryan
SDSergey Donakanyan
Sergey Donakanyan
OBOlga Bockeria
Olga Bockeria
Background: Understanding of the risk factors for the development of adverse outcomes after aortic valve replacement is necessary to develop timely preventive measures and to improve the results of surgical treatment. Methods: We analyzed patients with aortic stenosis (n = 742) who underwent surgical treatment in the period 2014–2020. The average age was 63 (57;69) years—men 58%, women 42%. Results: The hospital mortality rate was 3% (22 patients). The following statistically significant threshold values (cut-off points) were obtained in the ROC analysis: aortic cross-clamp time > 93 min AUC (CI) 0.676 (0.640–0.710), p = 0.010; cardiopulmonary bypass time > 144 min AUC (CI) 0.809 (0.778–0.837), p < 0.0001, hemoglobin before op <120 g/L. AUC (CI) 0.762 (0.728–0.793), p < 0.0001, hematocrit before op <39% AUC (CI) 0.755 (0.721–0.786), p < 0.001, end-diastolic dimension index >2.39 AUC (CI) 0.647 (0.607–0.686), p = 0.014, end-systolic dimension index > 1.68 AUC (CI) 0.657 (0.617–0.695), p = 0.009. Statistically significant independent predictors of hospital mortality were identified: BMI > 30 kg/m2 (OR 2.84; CI 1.15–7.01), ischemic heart disease (OR 3.65; CI 1.01–13.2), diabetes (OR 3.88; CI 1.38–10.9), frequent ventricular ectopy before operation (OR 9.78; CI 1.91–50.2), mitral valve repair (OR 4.47; CI 1.76–11.3), tricuspid valve repair (OR 3.06; CI 1.09–8.58), 3 and more procedures (OR 4.44; CI 1.67–11.8). Conclusions: The hospital mortality rate was 3%. The main indicators associated with the risk of death were: diabetes, overweight (body mass index more than 30 kg/m2), frequent ventricular ectopy before surgery, hemoglobin level below 120 g/L, hematocrit level below 39%, longer cardiopulmonary bypass time and aortic cross-clamp time, additional mitral and tricuspid valve interventions.

10 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SKSofia Kruchinova
Sofia Kruchinova
MGMilana Gendugova
Milana Gendugova
Alim NamitokovAlim Namitokov
Alim Namitokov
MSMaria Sokolskaya
Maria Sokolskaya
IGIrina Gilevich
Irina Gilevich
Vladimir ShvartzVladimir Shvartz
Vladimir Shvartz
Background: Despite the vast evidence of the beneficial effect of vagus nerve stimulation on the course of myocardial infarction confirmed in studies using animal models, the introduction of this method into actual clinical practice remains uncommon. Objective: The objective of our study was to evaluate the effect of transcutaneous vagus nerve stimulation (tVNS) on in-hospital and long-term outcomes for patients with ST-elevation myocardial infarction. Materials and Methods: A blind, randomized, placebo-controlled clinical trial was conducted. The participants were randomly split into two groups. The Active tVNS group was subjected to stimulation of the tragus containing the auricular branch of the vagus nerve. The Sham tVNS group underwent stimulation of the lobule. Stimulation was performed immediately on admission before the start of the percutaneous coronary intervention (PCI). Then, tVNS continued throughout the entire PCI procedure and 30 min after its completion. The primary endpoints were hospital mortality and 12-month mortality. The secondary endpoints were in-hospital and remote non-lethal cardiovascular events. The combined endpoint consisted of major adverse cardiovascular events (MACEs)—recurrent myocardial infarction, stroke/TIA, and overall mortality. Results: A total of 110 patients were randomized into the Active tVNS group (n = 55) and the Sham tVNS group (n = 55). The incidences of hospital mortality, cardiogenic shock, and AV block 3 were statistically less common in the Active tVNS group than in the Sham tVNS group (p = 0.024*, p = 0.044*, and p = 0.013*, respectively). In the long-term period, no statistical differences were found in the studied outcomes obtained following the construction of Kaplan–Meyer survival curves. When comparing groups by total mortality, taking into account hospital mortality, we observed a tendency for the survival curves to diverge (Logrank test, p = 0.066). Statistical significance was revealed by the composite endpoint, taking into account hospital events (Logrank test, p = 0.0016*). Conclusions: tVNS significantly reduced hospital mortality (p = 0.024*), the level of markers of myocardial damage, and the frequency of severe cardiac arrhythmias in patients with acute myocardial infarction. In the long term, the prognostic value of tVNS was revealed by the composite endpoint major adverse cardiovascular events. Further studies with an expanded sample are needed for a more detailed verification of the data obtained to confirm the effectiveness of tVNS and allow an in-depth analysis of the safety and feasibility of its use in routine clinical practice. This clinical trial is registered with ClinicalTrials database under a unique identifier: NCT05992259.

12 July 2021 in Health Care of the Russian Federation
Verified
Journal Article
Closed access
PDF file
MSMaria Sokolskaya
Maria Sokolskaya
Vladimir ShvartzVladimir Shvartz
Vladimir Shvartz
EHEleonora A. Hugaeva
Eleonora A. Hugaeva
OBOlga L. Bockeria
Olga L. Bockeria
МСМария Александровна Сокольская
Мария Александровна Сокольская
Modern medicine develops rapidly in the digital direction, and new information and telemedicine technologies are actively introduced in clinical practice. Purpose. To identify the category of cardiac surgical patients interested in the remote dynamic follow-up after the discharge from the hospital, using the Internet services and the factors that affect this. Material and methods. The study was conducted at the base of the department of surgical treatment of interactive pathology of the Bakoulev National Medical Research Center for Cardiovascular Surgery of the Russian Federation. The study was prospective. Before the discharge, patients answered a series of questions combined into an anonymous questionnaire. The questions concerned education, social status of the patient, age, gender, patient interest in remote follow up after discharge, use of the Internet and social networks, satisfaction with the treatment. Results. The study included 652 patients with a mean age of 58±12.5 years. 44% of them were women, 56% were men. More than 85% of patients expressed a positive opinion about such an initiative as using web services for remote consulting. Further analysis was aimed to identify possible differences between those patients who answered positively about remote follow up and those who were not interested. Statistically significant differences were revealed in the following indicators: education, sex, age, frequency of Internet use, use of social networks, place of residence and work status. Conclusions. The study confirms the demand among patients for the availability of services for their remote follow-up, which would perform the function of providing expert advice and the storage of archives of patients’ medical documents. Younger patients who are active Internet users and who have university education are potentially interested in this service. Such services would allow the patient to keep in touch with the doctor of the Department where surgical treatment was carried out, which would undoubtedly increase patients’ adherence to the treatment and recommendations.